17 Jul 2025
09:05 CEST |
OXURION |
Oxurion Secures Financing for the Acquisition of Axiodis CRO and Targets Closing on August 1, 2025
|
20103010 Biotechnology |
Alliances and agreements, Mergers, Acquisitions, Transfers |
17 Jul 2025
09:00 CEST |
OXURION |
Oxurion sécurise le financement de l'acquisition d'Axiodis CRO et projette un closing de l'opération au 1eraoût 2025
|
20103010 Biotechnology |
Alliances and agreements, Mergers, Acquisitions, Transfers |
17 Jul 2025
08:30 CEST |
OXURION |
Oxurion sécurise le financement de l'acquisition d'Axiodis CRO et projette un closing de l'opération au 1er août 2025
|
20103010 Biotechnology |
Alliances and agreements, Mergers, Acquisitions, Transfers |
17 Jul 2025
08:30 CEST |
OXURION |
Oxurion Secures Financing for the Acquisition of Axiodis CRO and Targets Closing on August 1, 2025
|
20103010 Biotechnology |
Alliances and agreements, Mergers, Acquisitions, Transfers |
15 Jul 2025
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
15 Jul 2025
18:00 CEST |
OXURION |
Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
14 Jul 2025
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
14 Jul 2025
18:00 CEST |
OXURION |
Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
10 Jul 2025
17:45 CEST |
OXURION |
Oxurion Announces the Fulfilment of the Second Condition Precedent in the Acquisition of Axiodis
|
20103010 Biotechnology |
Alliances and agreements, Mergers, Acquisitions, Transfers |
10 Jul 2025
17:45 CEST |
OXURION |
Oxurion annonce la levée de la seconde condition suspensive dans l'acquisition d'Axiodis
|
20103010 Biotechnology |
Alliances and agreements, Mergers, Acquisitions, Transfers |
04 Jul 2025
18:00 CEST |
OXURION |
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
|
20103010 Biotechnology |
Change in Capital |
04 Jul 2025
18:00 CEST |
OXURION |
Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie
|
20103010 Biotechnology |
Change in Capital |
03 Jul 2025
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
03 Jul 2025
18:00 CEST |
OXURION |
Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
30 Jun 2025
18:00 CEST |
OXURION |
Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
30 Jun 2025
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
25 Jun 2025
18:00 CEST |
OXURION |
Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
25 Jun 2025
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
19 Jun 2025
08:30 CEST |
OXURION |
Oxurion signs a letter of intent for the planned acquisition of a preclinical microbiology CRO to diversify and strengthen its presence in the Toulouse region
|
20103010 Biotechnology |
Alliances and agreements, Mergers, Acquisitions, Transfers |
19 Jun 2025
08:30 CEST |
OXURION |
Oxurion signe une lettre d'intention pour l'acquisition projetée d'une CRO de services précliniques en microbiologie afin de se diversifier et de renforcer sa présence en région toulousaine
|
20103010 Biotechnology |
Alliances and agreements, Mergers, Acquisitions, Transfers |
18 Jun 2025
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
18 Jun 2025
18:00 CEST |
OXURION |
Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
12 Jun 2025
18:00 CEST |
OXURION |
Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
12 Jun 2025
18:00 CEST |
OXURION |
Oxurion ontvangt aangepaste transparantiekennisgevingen van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
12 Jun 2025
08:30 CEST |
OXURION |
Oxurion avance dans l'acquisition projetée d'Axiodis
|
20103010 Biotechnology |
Alliances and agreements, Mergers, Acquisitions, Transfers |
12 Jun 2025
08:30 CEST |
OXURION |
Oxurion moves forward with the planned acquisition of Axiodis
|
20103010 Biotechnology |
Alliances and agreements, Mergers, Acquisitions, Transfers |
11 Jun 2025
18:00 CEST |
OXURION |
Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
11 Jun 2025
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
04 Jun 2025
18:00 CEST |
OXURION |
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
|
20103010 Biotechnology |
Change in Capital |
04 Jun 2025
18:00 CEST |
OXURION |
Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
04 Jun 2025
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
04 Jun 2025
18:00 CEST |
OXURION |
Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie
|
20103010 Biotechnology |
Change in Capital |
28 May 2025
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
28 May 2025
18:00 CEST |
OXURION |
Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
22 May 2025
18:00 CEST |
OXURION |
Oxurion kondigt resultaten aan van de Jaarlijkse Aandeelhoudersvergadering van 13 mei 2025
|
20103010 Biotechnology |
General meeting / Board Meeting, Meetings / events |
22 May 2025
18:00 CEST |
OXURION |
Oxurion Announces Results on the Annual Shareholders' Meeting of 13 May 2025
|
20103010 Biotechnology |
General meeting / Board Meeting, Meetings / events |
20 May 2025
18:00 CEST |
OXURION |
Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
20 May 2025
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
16 May 2025
08:30 CEST |
OXURION |
Oxurion announces the signing of a binding agreement to acquire French biometrics specialist Axiodis CRO
|
20103010 Biotechnology |
Alliances and agreements, Mergers, Acquisitions, Transfers |
16 May 2025
08:30 CEST |
OXURION |
Oxurion annonce la signature de l'accord ferme d'acquisition du français Axiodis CRO, spécialiste français de la biométrie
|
20103010 Biotechnology |
Alliances and agreements, Mergers, Acquisitions, Transfers |
15 May 2025
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
15 May 2025
18:00 CEST |
OXURION |
Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
12 May 2025
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
12 May 2025
18:00 CEST |
OXURION |
Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
09 May 2025
18:00 CEST |
OXURION |
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
|
20103010 Biotechnology |
Change in Capital |
09 May 2025
18:00 CEST |
OXURION |
Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie
|
20103010 Biotechnology |
Change in Capital |
25 Apr 2025
18:30 CEST |
OXURION |
Oxurion kondigt stopzetting aan van de transactie van juli 2024 en bevestigt de voortzetting van de gesprekken over het overnameproject aangekondigd in maart 2025
|
20103010 Biotechnology |
Alliances and agreements, Mergers, Acquisitions, Transfers |
25 Apr 2025
18:30 CEST |
OXURION |
Oxurion annonce l'arrêt de la transaction de juillet 2024 et confirme la poursuite des discussions sur le projet d'acquisition annoncé en mars 2025
|
20103010 Biotechnology |
Alliances and agreements, Mergers, Acquisitions, Transfers |
25 Apr 2025
18:30 CEST |
OXURION |
Oxurion announces that the transaction of July 2024 is stopped and confirms continuation of discussions regarding the acquisition project announced in March 2025
|
20103010 Biotechnology |
Alliances and agreements, Mergers, Acquisitions, Transfers |
11 Apr 2025
20:05 CEST |
OXURION |
Publication Annual Report - Annual Shareholders' Meeting
|
20103010 Biotechnology |
General meeting / Board Meeting, Meetings / events |